Search
Close this search box.

Merck-NJII Biopharmaceutical Training Acceleration Proposal (BTAP)

Performance Period: 2/1/2019 – 7/31/2019 The purpose of the Merck-NJII Biopharmaceutical Training Acceleration Proposal (BTAP) is to provide funding for the development of a training program to enable incumbent employees in the biopharmaceutical industry
Categories
Incumbent worker training
Talent/ Pipeline development
Project status
100% Completed

Solution

Performance Period: 2/1/2019 to 7/31/2019

 

 

The purpose of the Merck-NJII Biopharmaceutical Training Acceleration Proposal (BTAP) is to provide funding for the development of a training program to enable incumbent employees in the biopharmaceutical industry to acquire competencies in the bioprocess development and manufacturing operations related to the biologics field. The proposal is led by Haro Hartounian, Ph.D. of the New Jersey Innovation Institute. He will serve as both the PI and the Project Manager. Steve Dziennik, Ph.D. and Kelly Woltornist of Merck will serve as co-PIs.

Updates, Related Publications, and Deliverables

  • Login to the NIIMBL member portal for access to project updates, related publications, and deliverables. 

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

New Jersey Innovation Institute

New Jersey Innovation Institute

Participating Organizations

Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC

Join Our Mailing List

MailChimp NIIMBL Mailing List Signup
Organization Type
How did you first hear about NIIMBL?